Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
|
Dec 2014
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Allogeneic Stem Cell Transplantations for elderly patients with Myelodysplastic Syndrome
|
Apr 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes
|
Apr 2019
|
Blood
|
myelodysplastic syndromes (MDS)
|
Eltrombopag mobilizes iron in patients with aplastic anemia
|
Apr 2018
|
Blood
|
aplastic anemia
|
Paroxysmal nocturnal hemoglobinuria
|
Sep 2014
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Genetics of Progression From MDS to Secondary Leukemia
|
Jul 2020
|
Blood
|
myelodysplastic syndromes (MDS)
|
Clinical decision‐making and treatment of myelodysplastic syndromes
|
Oct 2023
|
Blood
|
myelodysplastic syndromes (MDS)
|
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.
|
Aug 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)
|
Jul 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
Recent developments in myelodysplastic syndromes
|
Sep 2014
|
Blood
|
myelodysplastic syndromes (MDS)
|